|
URGN Urogen Pharma Ltd 1668243 |
| Balance Sheet |
|
Current Assets
|
295,097,000 |
|
Assets
|
301,943,000 |
|
Current Liabilities
|
32,787,000 |
|
Liabilities
|
276,428,000 |
|
Equity
|
25,515,000 |
|
Shares Out
|
42,114,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-83,147,000 |
|
Investing Cash Flow
|
-81,234,000 |
| Market Analysis |
Market Cap
|
545,166,623 |
|
Price
|
11.76 |
|
BVPS
|
0.61 |
|
PB
|
19.21 |
|
EPS
|
-3.27 |
|
PS
|
5.41 |
|
FCF
|
-164,381,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view URGN documents filed with the SEC.
URGN Filings
Clear
